BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35606334)

  • 1.
    Jackson IM; Webb EW; Scott PJH; James ML
    ACS Chem Neurosci; 2022 Jun; 13(12):1675-1683. PubMed ID: 35606334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography in CNS drug discovery and drug monitoring.
    Piel M; Vernaleken I; Rösch F
    J Med Chem; 2014 Nov; 57(22):9232-58. PubMed ID: 25144329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency gains in tracer identification for nuclear imaging: can in vivo LC-MS/MS evaluation of small molecules screen for successful PET tracers?
    Joshi EM; Need A; Schaus J; Chen Z; Benesh D; Mitch C; Morton S; Raub TJ; Phebus L; Barth V
    ACS Chem Neurosci; 2014 Dec; 5(12):1154-63. PubMed ID: 25247893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a PET/SPECT Radiopharmaceutical in Oncology.
    Pisaneschi F; Viola NT
    Mol Imaging Biol; 2022 Feb; 24(1):1-7. PubMed ID: 34542804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A philosophy for CNS radiotracer design.
    Van de Bittner GC; Ricq EL; Hooker JM
    Acc Chem Res; 2014 Oct; 47(10):3127-34. PubMed ID: 25272291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET Radiotracers for CNS-Adrenergic Receptors: Developments and Perspectives.
    Alluri SR; Kim SW; Volkow ND; Kil KE
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32899124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying novel radiotracers for PET imaging of the brain: application of LC-MS/MS to tracer identification.
    Barth V; Need A
    ACS Chem Neurosci; 2014 Dec; 5(12):1148-53. PubMed ID: 24828747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Cholinergic Receptors in the Brain by Positron Emission Tomography.
    Zhang JJ; Fu H; Lin R; Zhou J; Haider A; Fang W; Elghazawy NH; Rong J; Chen J; Li Y; Ran C; Collier TL; Chen Z; Liang SH
    J Med Chem; 2023 Aug; 66(16):10889-10916. PubMed ID: 37583063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of structural alterations on the radiopharmacological profile of
    Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
    Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).
    Shokeen M; Anderson CJ
    Acc Chem Res; 2009 Jul; 42(7):832-41. PubMed ID: 19530674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production.
    Schopf E; Waldmann CM; Collins J; Drake C; Slavik R; van Dam RM
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotracers for positron emission tomography imaging.
    Gillings N
    MAGMA; 2013 Feb; 26(1):149-58. PubMed ID: 23242769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemistry Considerations for the Clinical Translation of Oncology PET Radiopharmaceuticals.
    Allott L; Aboagye EO
    Mol Pharm; 2020 Jul; 17(7):2245-2259. PubMed ID: 32433888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging in Central Nervous System Drug Discovery.
    Gunn RN; Rabiner EA
    Semin Nucl Med; 2017 Jan; 47(1):89-98. PubMed ID: 27987561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in [
    Francis F; Wuest F
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET).
    Banister SD; Manoli M; Kassiou M
    J Labelled Comp Radiopharm; 2013; 56(3-4):215-24. PubMed ID: 24285328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of diverse PET probes with limited resources: 24
    Collins J; Waldmann CM; Drake C; Slavik R; Ha NS; Sergeev M; Lazari M; Shen B; Chin FT; Moore M; Sadeghi S; Phelps ME; Murphy JM; van Dam RM
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11309-11314. PubMed ID: 29073049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiopharmaceutical chemistry for positron emission tomography.
    Li Z; Conti PS
    Adv Drug Deliv Rev; 2010 Aug; 62(11):1031-51. PubMed ID: 20854860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.